{"title":"带目的地左心室辅助装置患者的SARS-CoV-2感染","authors":"G. Careaga-Reyna, H. Zetina-Tun","doi":"10.15406/jlprr.2021.08.00255","DOIUrl":null,"url":null,"abstract":"Recipients of LVAD for destination therapy may represent a challenge in the treatment of COVID-19. We present a case of a 58 year-old male with LVAD support complicated with SARS-CoV-2 who declines for hospital admission despite interstitial pneumonia and lower O2 saturation. The patient recieved ambulatory support and treatment with anticoagulation, supplementary O2, steroids, antibiotics, ivermectin with succesful evolution and recovery.","PeriodicalId":91750,"journal":{"name":"Journal of lung, pulmonary & respiratory research","volume":"44 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"SARS-CoV-2 infection in a patient with destination left ventricular assist device\",\"authors\":\"G. Careaga-Reyna, H. Zetina-Tun\",\"doi\":\"10.15406/jlprr.2021.08.00255\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Recipients of LVAD for destination therapy may represent a challenge in the treatment of COVID-19. We present a case of a 58 year-old male with LVAD support complicated with SARS-CoV-2 who declines for hospital admission despite interstitial pneumonia and lower O2 saturation. The patient recieved ambulatory support and treatment with anticoagulation, supplementary O2, steroids, antibiotics, ivermectin with succesful evolution and recovery.\",\"PeriodicalId\":91750,\"journal\":{\"name\":\"Journal of lung, pulmonary & respiratory research\",\"volume\":\"44 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of lung, pulmonary & respiratory research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15406/jlprr.2021.08.00255\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of lung, pulmonary & respiratory research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/jlprr.2021.08.00255","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
SARS-CoV-2 infection in a patient with destination left ventricular assist device
Recipients of LVAD for destination therapy may represent a challenge in the treatment of COVID-19. We present a case of a 58 year-old male with LVAD support complicated with SARS-CoV-2 who declines for hospital admission despite interstitial pneumonia and lower O2 saturation. The patient recieved ambulatory support and treatment with anticoagulation, supplementary O2, steroids, antibiotics, ivermectin with succesful evolution and recovery.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
